CORCEPT THERAPEUTICS INC Prepaid Expense, Current
CORCEPT THERAPEUTICS INC (CORT) had Prepaid Expense, Current of $17.57 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidExpenseCurrent · last filed 2026-07-29
- 2026-06-30: Prepaid Expense, Current $17.57M.
- 2026-03-31: Prepaid Expense, Current $19.86M.
- 2025-12-31: Prepaid Expense, Current $8.69M; Prepaid Expense, Current as first filed $23.26M.
- 2025-09-30: Prepaid Expense, Current $22.98M.
| Period end | Prepaid Expense, Current | Prepaid Expense, Current as first filed |
|---|---|---|
| 2026-06-30 | $17.57M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $19.86M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $8.69M 10-Q · filed 2026-07-29 | $23.26M 10-K · filed 2026-02-24 |
| 2025-09-30 | $22.98M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $9.69M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $8.55M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $9.49M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $5.82M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $5.15M 10-Q · filed 2024-07-29 | |
| 2024-03-31 | $5.54M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $4.32M 10-K · filed 2025-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |